InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Atom0aks post# 224287

Monday, 11/11/2019 12:06:08 PM

Monday, November 11, 2019 12:06:08 PM

Post# of 426436
A-

The subgroup HIERARCHY was prespecified not this analysis of only looking at USA patient

Are u serious? I nominate your post in a "weakest argument ever" category …

This prespecified subgroup analysis of Reduction of Cardiovascular Events with Icosapent Ethyl - Intervention Trial (REDUCE-IT)

Meanwhile the hierarchy was prespecified also … it is about the analysis. From your link …

Therefore, we sought to explore the prespecified subgroup of patients from REDUCE-IT enrolled in the USA to determine the effects of icosapent ethyl.

Don't be a Black Knight …

Best,
G

"There are some things money can't buy. … For these, there is AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News